P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

OBJECTIVE: To assess the risks and benefits of P2Y(12) inhibitor monotherapy compared with dual antiplatelet therapy (DAPT) and whether these associations are modified by patients’ characteristics. DESIGN: Individual patient level meta-analysis of randomised controlled trials. DATA SOURCES: Searches...

Descripción completa

Detalles Bibliográficos
Autores principales: Valgimigli, Marco, Gragnano, Felice, Branca, Mattia, Franzone, Anna, Baber, Usman, Jang, Yangsoo, Kimura, Takeshi, Hahn, Joo-Yong, Zhao, Qiang, Windecker, Stephan, Gibson, Charles M, Kim, Byeong-Keuk, Watanabe, Hirotoshi, Song, Young Bin, Zhu, Yunpeng, Vranckx, Pascal, Mehta, Shamir, Hong, Sung-Jin, Ando, Kenji, Gwon, Hyeon-Cheol, Serruys, Patrick W, Dangas, George D, McFadden, Eùgene P, Angiolillo, Dominick J, Heg, Dik, Jüni, Peter, Mehran, Roxana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207247/
https://www.ncbi.nlm.nih.gov/pubmed/34135011
http://dx.doi.org/10.1136/bmj.n1332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207247/
https://www.ncbi.nlm.nih.gov/pubmed/34135011
http://dx.doi.org/10.1136/bmj.n1332

Ejemplares similares